SLC5A2 and polycystic ovary syndrome: Although common therapeutics used as adjunct therapies for the management of metabolic syndrome in PCOS include metformin, thiazolidinediones, inositols, dipeptidyl peptidase-IV (DPP-IV) inhibitors, and sodium-glucose cotransporter-2 inhibitors (SGLT-2), the potential utility of GLP-1 RA use remains understudied [7].